服務(wù)熱線
18915418616
您好，歡迎光臨蘇州螞蟻淘生物科技有限公司
服務(wù)熱線：18915418616
簡要描述：MatriksBiotek品牌產(chǎn)品列表介紹MatrikSBIotek®Co。，作為一家成立于2002年的生物技術(shù)公司，正在慶祝其15年的業(yè)務(wù)。 以生產(chǎn)為導(dǎo)向的公司致力于研究和創(chuàng)新免疫，分子和工具，將有助于健康。 在市場上使用生物藥物測試SHIKARI®ELISA試劑盒，自從在市場上*生產(chǎn)和商業(yè)化以來已有10年的歷史。
產(chǎn)品型號： 廠商性質(zhì)：經(jīng)銷商更新時間：2019-04-23訪 問 量：1423MatriksBiotek品牌產(chǎn)品列表介紹
MatrikSBIotek®Co。，作為一家成立于2002年的生物技術(shù)公司，正在慶祝其15年的業(yè)務(wù)。 以生產(chǎn)為導(dǎo)向的公司致力于研究和創(chuàng)新免疫，分子和工具，將有助于健康。 在市場上使用生物藥物測試SHIKARI®ELISA試劑盒，自從在市場上*生產(chǎn)和商業(yè)化以來已有10年的歷史。
在36個國家和30多家制藥公司充滿信心地使用和/或使用我們的產(chǎn)品。 生物制劑（主要是人源化重組單克隆抗體）在某些疾病中作為藥物的使用引起每個單獨治療的人的有效性問題。 監(jiān)測藥物水平和抗體在管理對重組和/或人源化抗體的反應(yīng)缺乏或喪失方面發(fā)揮著新的作用（即，確認治療持續(xù)，劑量調(diào)整，提供轉(zhuǎn)換為另一種藥劑或不同藥劑的理由 一類生物制劑）。
MatriksBiotek品牌產(chǎn)品列表介紹
MatrikSBIotek介紹
| Reference Code | Product Name | Description |
|---|---|---|
| TR-Q-INFLIXIv2 | Q-INFLIXI | Enzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma |
| TR-ATIv5 | Q-ATI | Enzyme immunoassay for the qualitative determination of specific antibodies to infliximab in human serum and plasma with confirmation |
| TR-ATIv6 | Q-ATI | Enzyme immunoassay for the quantitative determination of specific antibodies to infliximab in human serum and plasma with confirmation |
| TR-ATIv8 | Q-ATI DUO | Enzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to infliximab (Remicade®) in serum and plasma. |
| TR-ADAv1 | Q-ADA | Enzyme immunoassay for the quantitative determination of free adalimumab (Humira®) in serum and plasma |
| TR-AADAv1 | S-ATA | Enzyme immunoassay for the qualitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation |
| TR-AADAv2 | S-ATA | Enzyme immunoassay for the quantitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation |
| TR-AADAv4 | S-ATA DUO | Enzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to adalimumab (Humira®) in serum and plasma |
| TR-ETAv2 | Q-ETA | Enzyme immunoassay for the quantitative determination of free Etanercept (Enbrel) in serum and plasma |
| TR-AETAv2 | S-ATE | Enzyme immunoassay for the qualitative determination of antibodies to etanercept in serum and plasma |
| TR-BEVAv2 | Q-BEVA | Enzyme immunoassay for the quantitative determination of Bevacizumab (Avastin®) in serum and plasma |
| TR-ABEVAv1 | S-ATB | Enzyme immunoassay for the qualitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma |
| TR-ABEVAv2 | S-ATB | Enzyme immunoassay for the quantitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma |
| TR-RTXv2 | Q-RITUX | Enzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma |
| TR-ARTXv1 | S-ATR | Enzyme immunoassay for the qualitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma |
| TR-ARTXv2 | S-ATR | Enzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma |
| TR-TRASv2 | Q-TRAS | Enzyme immunoassay for the quantitative determination of Trastuzumab (Herceptin®, Herclon®) |
| TR-ATRASv1 | S-ATT | Enzyme immunoassay for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma |
| TR-ATRASv2 | S-ATT | Enzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma |
| TR-GOLv1 | Q-GOL | Enzyme immunoassay for the quantitative determination of free Golimumab (Simponi®) in serum and plasma. |
| TR-ATGv1 | S-ATG | Enzyme immunoassay for the qualitative determination of antibodies to Golimumab in serum and plasma. |
| TR-CETv1 | Q-CET | Enzyme immunoassay for the quantitative determination of free Cetuximab (Erbitux®) in serum and plasma. |
| TR-ATCv1 | S-ATC | Enzyme immunoassay for the qualitative determination of antibodies to cetuximab in serum and plasma. |
| TR-ATCv2 | S-ATC | Enzyme immunoassay for the quantitative determination of antibodies to cetuximab in serum and plasma. |
| TR-REMSv1 | Q-REMS | Enzyme immunoassay for the quantitative determination of free Infliximab (Remsima®) in serum and plasma. |
| TR-AREMSv1 | S-AIR | Enzyme immunoassay for the qualitative determination of antibodies to Infliximab Remsima in serum and plasma. |
| TR-AREMSv2 | S-AIR | Enzyme immunoassay for the quantitative determination of antibodies to Infliximab Remsima in serum and plasma. |
| TR-AREMSv3 | S-AIR | Enzyme immunoassay for the semi-quantitative determination (screening) of total antibodies to Infliximab biosimilar (Remsima®) in serum and plasma. |
| TR-QDENv1 | Q-DEN | Enzyme immunoassay for the quantitative determination of Denosumab (Prolia®)in serum and plasma. |
| TR-AATDv1 | S-ATD | Enzyme immunoassay for the qualitative determination of antibodies to Denosumab in serum and plasma. |
| TR-OMAv1 | Q-OMA | Enzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) Remsima in serum and plasma. |
| TR-AATOv1 | S-ATO | Enzyme immunoassay for the qualitative determination of antibodies to Omalizumab in serum and plasma. |
| TR-Q-NIVOv1 | Q-NIVO | Enzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma. |
| TR-ATNv1 | S-ATN | Enzyme immunoassay for the qualitative determination of antibodies to Nivolumab in serum and plasma. |
| TR-PEMv1 | Q-PEM | Enzyme immunoassay for the quantitative determination of Pembrolizumab (Keytruda®) in serum and plasma. |
| TR-A-PEMv1 | S-ATP | Enzyme immunoassay for the qualitative determination of antibodies to Pembrolizumab in serum and plasma. |
| TR-AFAv1 | Q-AFA | Enzyme immunoassay for the quantitative determination of specific anibodies to Filgrastim in serum and plasma. |
| TR-IPIv1 | Q-IPI | Enzyme immunoassay for the quantitative determination of specific Ipilimumab(Yervoy®) in human serum and plasma. |
| TR-AIPIv1 | S-ATI | Enzyme immunoassay for the qualitative determination of specific anibodies to Ipilimumab in serum and plasma. |
| TR-Q-AVEv1 | Q-AVE | Enzyme immunoassay for the quantitative determination of specific Avelumab(Bavencio®) in human serum and plasma. |
| TR-A-AVEv1 | S-ATAV | Enzyme immunoassay for the qualitative determination of specific anibodies to Avelumab in serum and plasma. |
| TR-RANv1 | Q-RAN | Enzyme immunoassay for the quantitative determination of free Ranibizumab in aqueous humour. |
| TR-RAMv1 | Q-RAM | Enzyme immunoassay for the quantitative determination of free Ramucirumab in serum and plasma. |
| TR-ARAMv1 | S-ATRAM | Enzyme immunoassay for the qualitative determination of antibodies to Ramucirumab in serum and plasma. |
| TR-CERTv2 | Q-CERT | Enzyme immunoassay for the quantitative determination of Certolizumab in human serum and plasma |
| TR-Q-VEDOv1 | Q-VEDO | Enzyme immunoassay for the quantitative determination of Vedolizumab in human serum and plasma |
| TR-ATVv1 | S-ATV | Enzyme immunoassay for the qualitative determination of antibodies to Vedolizumab in human serum and plasma |
| TR-Q-USTv1 | Q-UST | Enzyme immunoassay for the quantitative determination of Ustekinumab in human serum and plasma |
| TR-AUSTv1 | S-ATU | Enzyme immunoassay for the qualitative determination of antibodies to Ustekinumab in human serum and plasma |
| 如果你對MatriksBiotek品牌產(chǎn)品列表介紹感興趣，想了解更詳細的產(chǎn)品信息，填寫下表直接與廠家聯(lián)系： |